Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis
Open accessThe DOI matches its Crossref record; 113 of the 114 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Type II focal cortical dysplasia (FCD) is a neuropathological entity characterised by cortical dyslamination with the presence of dysmorphic neurons only (FCDIIA) or the presence of both dysmorphic neurons and balloon cells (FCDIIB). The year 2021 marks the 50th anniversary of the recognition of FCD as a cause of drug resistant epilepsy, and it is now the most common reason for epilepsy surgery. The causes of FCD remained unknown until relatively recently. The study of resected human FCD tissue using novel genomic technologies has led to remarkable advances in understanding the genetic basis of FCD. Mechanistic parallels have emerged between these non-neoplastic lesions and neoplastic disorders of cell growth and differentiation, especially through perturbations of the mammalian target of rapamycin (mTOR) signalling pathway. This narrative review presents the advances through which the aetiology of FCDII has been elucidated in chronological order, from recognition of an association between FCD and the mTOR pathway to the identification of somatic mosaicism within FCD tissue. We discuss the role of a two-hit mechanism, highlight current challenges and future directions in detecting somatic mosaicism in brain and discuss how knowledge of FCD may inform novel precision treatments of these focal epileptogenic malformations of human cortical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Germline LOF variants in proteins that comprise the GATOR1 complex (DEPDC5, NPRL2, NPRL3), responsible for sensing amino acid levels, cause both nonlesional focal epilepsy and epilepsy associated with focal cortical dysplasia (FCD) type II 122 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [122]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Somatic mosaicism can be found in brain-derived DNA at low levels on surgical specimens, cerebrospinal fluid or implanted EEG electrodes 122, 177, 178 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [122]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“These downstream phosphorylated substrates, including phosphorylated ribosomal protein S6 (p-S6), are a result of the serine/threonine kinase activity of mTOR [23].”
BackgroundmTOR at the nexus of nutrition, growth, ageing and disease
Liu, G. Y., & Sabatini, D. M. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0199-y · Cited by 2,737 · cited 3×
“In the brain, the mTOR pathway also has specific roles during both develop‐ ment and adulthood (reviewed in [20]).”
BackgroundInfluentialMode of cell migration to the superficial layers of fetal monkey neocortex
Rakic, P. (1972) · Journal of Comparative Neurology · doi:10.1002/cne.901450105 · Cited by 2,170 · cited 2×
“During corticogenesis, pyrami‐ al neurons migrate long distances in a radial fashion, from the ventricular zone to the different layers of cortex [96].”
BackgroundA mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
Blümcke, I., Thom, M., Aronica, E., Armstrong, D. D., Vinters, H. V., Palmini, A., Jacques, T. S., Avanzini, G., Barkovich, A. J., Battaglia, G., et al. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2010.02777.x · Cited by 1,743 · cited 1×
“The most recent classification established by the International League Against Epilepsy [6] proposed three FCD subtypes: FCD type I (FCDI) exhibits abnormal radial and/or tangential lamination; FCD type II (FCDII) is characterised by abnormal lamination and the presence of an abnormal cell type; and when FCDI co-exist…”
BackgroundVÉZINA, C., KUDELSKI, A., & SEHGAL, S. N. (1975) · The Journal of Antibiotics · doi:10.7164/antibiotics.28.721 · Cited by 1,687
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648 · cited 1×
“While the genetic causes of FCD remained unclear until relatively recently, early linkage studies attributed TSC to two disease-causing loci located on chromosome 9 and 16 [8,9], and the two genes were eventually identified and termed TSC1 and TSC2 respectively [10,11].”
BackgroundIdentification and characterization of the tuberous sclerosis gene on chromosome 16
(1993) · Cell · doi:10.1016/0092-8674(93)90618-z · Cited by 1,645
Sabatini, D. M., Erdjument-Bromage, H., Lui, M., Tempst, P., & Snyder, S. H. (1994) · Cell · doi:10.1016/0092-8674(94)90570-3 · Cited by 1,509
Interneuron Migration from Basal Forebrain to Neocortex: Dependence on Dlx Genes
Anderson, S. A., Eisenstat, D. D., Shi, L., & Rubenstein, J. L. R. (1997) · Science · doi:10.1126/science.278.5337.474 · Cited by 1,462 · cited 2×
“In contrast, interneurons originate from ganglio ic emi‐ nence and migrate in a tangential direction before entering the cortex [97].”
BackgroundTwo genetic hits (more or less) to cancer
Knudson, A. G. (2001) · Nature Reviews Cancer · doi:10.1038/35101031 · Cited by 1,127 · cited 2×
“The exact mechanism was not fully understood, but the authors suggested that a two-hit mechanism, analogous to the two-hit cancer model [40] may be involved.”
BackgroundResultA developmental and genetic classification for malformations of cortical development: update 2012
Barkovich, A. J., Guerrini, R., Kuzniecky, R. I., Jackson, G. D., & Dobyns, W. B. (2012) · Brain · doi:10.1093/brain/aws019 · Cited by 1,104 · cited 1×
“First described in 1835 [24], hemimegalencephaly (HME) is a cortical malformation characterised by abnormal enlargement of one cerebral hemisphere, with histopathological features generally indistinguishable from those of FCDII [25,26].”
BackgroundBar-Peled, L., Chantranupong, L., Cherniack, A. D., Chen, W. W., Ottina, K. A., Grabiner, B. C., Spear, E. D., Carter, S. L., Meyerson, M., & Sabatini, D. M. (2013) · Science · doi:10.1126/science.1232044 · Cited by 1,080 · cited 2×
“DEPDC5 is a component of the GATOR1 complex [36], which functions as a repressor in the amino acid-sensing branch mTOR path-”
BackgroundFocal dysplasia of the cerebral cortex in epilepsy
Taylor, D. C., Falconer, M. A., Bruton, C. J., & Corsellis, J. A. N. (1971) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.34.4.369 · Cited by 1,073 · cited 3×
“Fifty years after the initial description of FCD [5], the field is now able to dissect the biology of FCD at unprecedented resolution using modern molecular techniques.”
BackgroundInfluentialHistopathological Findings in Brain Tissue Obtained during Epilepsy Surgery
Blumcke, I., Spreafico, R., Haaker, G., Coras, R., Kobow, K., Bien, C. G., Pfäfflin, M., Elger, C., Widman, G., Schramm, J., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703784 · Cited by 931 · cited 1×
“6% of these specimens corresponded to different FCD subtypes [1].”
BackgroundIsolation of a Protein Target of the FKBP12-Rapamycin Complex in Mammalian Cells
Sabers, C. J., Martin, M. M., Brunn, G. J., Williams, J. M., Dumont, F. J., Wiederrecht, G., & Abraham, R. T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.815 · Cited by 887
French, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Berkowitz, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31419-2 · Cited by 764
De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
Lee, J. H., Huynh, M., Silhavy, J. L., Kim, S., Dixon-Salazar, T., Heiberg, A., Scott, E., Bafna, V., Hill, K. J., Collazo, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2329 · Cited by 703 · cited 1×
“In 2012, Lee and colleagues used whole exome sequencing (WES) on paired blood and brain specimens from five individuals with HME and identified brain-specific somatic variants in three [33].”
BackgroundPrimary Cilia and Mammalian Hedgehog Signaling
Bangs, F., & Anderson, K. V. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028175 · Cited by 642
Somatic mutation, genomic variation, and neurological disease
Poduri, A., Evrony, G. D., Cai, X., & Walsh, C. A. (2013) · Science · doi:10.1126/science.1237758 · Cited by 584 · cited 2×
“It has been proposed that the extent of brain malformation is de‐ termined by the timing of the genetic insult [61].”
BackgroundSomatic mutation in single human neurons tracks developmental and transcriptional history
Lodato, M. A., Woodworth, M. B., Lee, S., Evrony, G. D., Mehta, B. K., Karger, A., Lee, S., Chittenden, T. W., D’Gama, A. M., Cai, X., et al. (2015) · Science · doi:10.1126/science.aab1785 · Cited by 570
Single-Neuron Sequencing Analysis of L1 Retrotransposition and Somatic Mutation in the Human Brain
Evrony, G. D., Cai, X., Lee, E., Hills, L. B., Elhosary, P. C., Lehmann, H. S., Parker, J. J., Atabay, K. D., Gilmore, E. C., Poduri, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.035 · Cited by 548
The Drosophila Tuberous Sclerosis Complex Gene Homologs Restrict Cell Growth and Cell Proliferation
Tapon, N., Ito, N., Dickson, B. J., Treisman, J. E., & Hariharan, I. K. (2001) · Cell · doi:10.1016/s0092-8674(01)00332-4 · Cited by 542
Potter, C. J., Huang, H., & Xu, T. (2001) · Cell · doi:10.1016/s0092-8674(01)00333-6 · Cited by 521
Lim, J. S., Kim, W.-I., Kang, H.-C., Kim, S. H., Park, A. H., Park, E. K., Cho, Y.-W., Kim, S., Kim, H. M., Kim, J. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3824 · Cited by 518
EVIDENCE THAT THE GENE FOR TUBEROUS SCLEROSIS IS ON CHROMOSOME 9
Fryer, A. E., Connor, J. M., Povey, S., Yates, J. R. W., Chalmers, A., Fraser, I., Yates, A. D., & Osborne, J. P. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90416-8 · Cited by 509 · cited 1×
“While the genetic causes of FCD remained unclear until relatively recently, early linkage studies attributed TSC to two disease-causing loci located on chromosome 9 and 16 [8,9], and the two genes were eventually identified and termed TSC1 and TSC2 respectively [10,11].”
BackgroundTwenty-five years of mTOR: Uncovering the link from nutrients to growth
Sabatini, D. M. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1716173114 · Cited by 501 · cited 2×
“Indeed, the identification of mTOR was mainly driven by the desire to understand the mechanism of action of rapamycin [19].”
BackgroundSomatic activation of AKT3 causes hemispheric developmental brain malformations
Poduri, A., Evrony, G. D., Cai, X., Elhosary, P. C., Beroukhim, R., Lehtinen, M. K., Hills, L. B., Heinzen, E. L., Hill, A., Hill, R. S., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.010 · Cited by 478 · cited 2×
“Poduri and colleagues used SNP microarray and quantitative PCR to identify mosaic trisomy of chromosome 1q in two individuals with HME [34].”
BackgroundTSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
Gao, X., & Pan, D. (2001) · Genes & Development · doi:10.1101/gad.901101 · Cited by 455
Grabiner, B. C., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S., Jordan, A., Beck, A. H., & Sabatini, D. M. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0929 · Cited by 450 · cited 1×
“Leu1460Pro), all of which were previously found to confer mTOR pathway hyperactivation [56].”
BackgroundSingle-Cell Whole-Genome Amplification and Sequencing: Methodology and Applications
Huang, L., Ma, F., Chapman, A., Lu, S., & Xie, X. S. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025352 · Cited by 423
Mutations in DEPDC5 cause familial focal epilepsy with variable foci
Dibbens, L. M., de Vries, B., Donatello, S., Heron, S. E., Hodgson, B. L., Chintawar, S., Crompton, D. E., Hughes, J. N., Bellows, S. T., Klein, K. M., et al. (2013) · Nature Genetics · doi:10.1038/ng.2599 · Cited by 373 · cited 2×
“Heterozygous germline variants in DEPDC5 were initially implicated in non-lesional (MRI-negative) familial focal epilepsy including familial focal epilepsy with variable foci, autosomal dominant nocturnal frontal epilepsy, and familial temporal lobe epilepsy [37,38].”
BackgroundLoss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
Green, A. J., Smith, M., & Yates, J. R. W. (1994) · Nature Genetics · doi:10.1038/ng0294-193 · Cited by 364
Jansen, L. A., Mirzaa, G. M., Ishak, G. E., O'Roak, B. J., Hiatt, J. B., Roden, W. H., Gunter, S. A., Christian, S. L., Collins, S., Adams, C., et al. (2015) · Brain · doi:10.1093/brain/awv045 · Cited by 364 · cited 1×
“In addition to MTOR, somatic variants in two other mTOR pathway genes, PIK3CA and AKT3, were implicated in FCD [57].”
BackgroundCerebral cortex expansion and folding: what have we learned?
Fernández, V., Llinares‐Benadero, C., & Borrell, V. (2016) · The EMBO Journal · doi:10.15252/embj.201593701 · Cited by 361 · cited 2×
“The occurrence of these rare somatic variants seen in FCD (typically < 5%) is, in part, due to the nature of cortical development [95].”
BackgroundDissecting the genetic basis of focal cortical dysplasia: a large cohort study
Baldassari, S., Ribierre, T., Marsan, E., Adle-Biassette, H., Ferrand-Sorbets, S., Bulteau, C., Dorison, N., Fohlen, M., Polivka, M., Weckhuysen, S., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02061-5 · Cited by 356 · cited 9×
“Glu40Val)], providing further support to the pathogenic role of RHEB variants [67].”
BackgroundMethodResultInfluentialSelf-citationMolecular genetic advances in tuberous sclerosis
Cheadle, J. P., Reeve, M. P., Sampson, J. R., & Kwiatkowski, D. J. (2000) · Human Genetics · doi:10.1007/s004390000348 · Cited by 349 · cited 1×
“TSC is a multisystem genetic syndrome characterised by benign tumours (or “hamartomas”) in multiple organs including the kidney, heart, and brain [7].”
BackgroundKandt, R. S., Haines, J. L., Smith, M., Northrup, H., Gardner, R. J. M., Short, M. P., Dumars, K., Roach, E. S., Steingold, S., Wall, S., et al. (1992) · Nature Genetics · doi:10.1038/ng0992-37 · Cited by 337 · cited 1×
“While the genetic causes of FCD remained unclear until relatively recently, early linkage studies attributed TSC to two disease-causing loci located on chromosome 9 and 16 [8,9], and the two genes were eventually identified and termed TSC1 and TSC2 respectively [10,11].”
BackgroundD’Gama, A. M., Woodworth, M. B., Hossain, A. A., Bizzotto, S., Hatem, N. E., LaCoursiere, C. M., Najm, I., Ying, Z., Yang, E., Barkovich, A. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.106 · Cited by 328
Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations
Baulac, S., Ishida, S., Marsan, E., Miquel, C., Biraben, A., Nguyen, D. K., Nordli, D., Cossette, P., Nguyen, S., Lambrecq, V., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24368 · Cited by 293 · cited 4×
“Arg239*) variant detected in blood and brain [45].”
BackgroundInfluentialSelf-citationD'Gama, A. M., Geng, Y., Couto, J. A., Martin, B., Boyle, E. A., LaCoursiere, C. M., Hossain, A., Hatem, N. E., Barry, B. J., Kwiatkowski, D. J., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24357 · Cited by 290 · cited 3×
“two individuals with FCD and a heterozygous germline DEPDC5 variant did not detect any somatic variants in DEPDC5 in affected brain tissue utilising molecular inversion probe sequencing (MIPS) and WES [46].”
BackgroundBagnall, R. D., Crompton, D. E., Petrovski, S., Lam, L., Cutmore, C., Garry, S. I., Sadleir, L. G., Dibbens, L. M., Cairns, A., Kivity, S., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24596 · Cited by 281
Mirzaa, G. M., Campbell, C. D., Solovieff, N., Goold, C. P., Jansen, L. A., Menon, S., Timms, A. E., Conti, V., Biag, J. D., Olds, C., et al. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.0363 · Cited by 273 · cited 8×
“9% mutant load in two individuals with FCD [51].”
BackgroundInfluentialMutations of DEPDC5 cause autosomal dominant focal epilepsies
Ishida, S., Picard, F., Rudolf, G., Noé, E., Achaz, G., Thomas, P., Genton, P., Mundwiller, E., Wolff, M., Marescaux, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2601 · Cited by 269 · cited 2×
“Heterozygous germline variants in DEPDC5 were initially implicated in non-lesional (MRI-negative) familial focal epilepsy including familial focal epilepsy with variable foci, autosomal dominant nocturnal frontal epilepsy, and familial temporal lobe epilepsy [37,38].”
BackgroundSelf-citationThe Epileptogenic Zone: Concept and Definition
Jehi, L. (2018) · Epilepsy Currents · doi:10.5698/1535-7597.18.1.12 · Cited by 260
mTOR cascade activation distinguishes tubers from focal cortical dysplasia
Baybis, M., Yu, J., Lee, A., Golden, J. A., Weiner, H., McKhann, G., Aronica, E., & Crino, P. B. (2004) · Annals of Neurology · doi:10.1002/ana.20211 · Cited by 255 · cited 5×
“The most remarkable outcome of the two studies was the consistent finding that in balloon/giant cells and dysmorphic neurons from both FCD and TSC, enhanced immunoreactivity against p-S6 was observed.”
BackgroundInfluentialRicos, M. G., Hodgson, B. L., Pippucci, T., Saidin, A., Ong, Y. S., Heron, S. E., Licchetta, L., Bisulli, F., Bayly, M. A., Hughes, J., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24547 · Cited by 246
Self-citationRibierre, T., Deleuze, C., Bacq, A., Baldassari, S., Marsan, E., Chipaux, M., Muraca, G., Roussel, D., Navarro, V., Leguern, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99384 · Cited by 241 · cited 4×
“9% mutant load in two individuals with FCD [62,66].”
BackgroundInfluentialSelf-citationThe landscape of epilepsy-related GATOR1 variants
Baldassari, S., Picard, F., Verbeek, N. E., van Kempen, M., Brilstra, E. H., Lesca, G., Conti, V., Guerrini, R., Bisulli, F., Licchetta, L., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-018-0060-2 · Cited by 240
Self-citationThe genomic landscape of tuberous sclerosis complex
Martin, K. R., Zhou, W., Bowman, M. J., Shih, J., Au, K. S., Dittenhafer-Reed, K. E., Sisson, K. A., Koeman, J., Weisenberger, D. J., Cottingham, S. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15816 · Cited by 238
Scheffer, I. E., Heron, S. E., Regan, B. M., Mandelstam, S., Crompton, D. E., Hodgson, B. L., Licchetta, L., Provini, F., Bisulli, F., Vadlamudi, L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24126 · Cited by 229 · cited 2×
“However, a subsequent study showed that DEPDC5 variants may also be associated with lesional focal epilepsy [39].”
BackgroundThe primary cilium as a cellular receiver: organizing ciliary GPCR signaling
Hilgendorf, K. I., Johnson, C. T., & Jackson, P. K. (2016) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2016.02.008 · Cited by 224
Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia
Lim, J. S., Gopalappa, R., Kim, S. H., Ramakrishna, S., Lee, M., Kim, W.-I., Kim, J., Park, S. M., Lee, J., Oh, J.-H., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.01.030 · Cited by 207 · cited 4×
“Val1547Ile) variant in one individual using targeted hybrid capture and PCR-based amplicon sequencing [58].”
BackgroundMethodInfluentialNiida, Y., Stemmer-Rachamimov, A. O., Logrip, M., Tapon, D., Perez, R., Kwiatkowski, D. J., Sims, K., MacCollin, M., Louis, D. N., & Ramesh, V. (2001) · The American Journal of Human Genetics · doi:10.1086/321972 · Cited by 205
Somatic Mutations in the MTOR gene cause focal cortical dysplasia type II b
Nakashima, M., Saitsu, H., Takei, N., Tohyama, J., Kato, M., Kitaura, H., Shiina, M., Shirozu, H., Masuda, H., Watanabe, K., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24444 · Cited by 196 · cited 4×
“Using laser capture microdissection, other studies have shown that somatic variants in HME and FCD were most highly enriched in dysmorphic neurons and/or balloon cells compared to other cell types [66,67,77].”
BackgroundInfluentialInvolvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia
Weckhuysen, S., Marsan, E., Lambrecq, V., Marchal, C., Morin‐Brureau, M., An‐Gourfinkel, I., Baulac, M., Fohlen, M., Kallay Zetchi, C., Seeck, M., et al. (2016) · Epilepsia · doi:10.1111/epi.13391 · Cited by 185 · cited 4×
“Similarly, low coverage WES (mean depth 80X) and Sanger sequencing of brain-derived DNA from two individuals with FCD and a germline heterozygous NPRL3 variant did not detect additional somatic variants [50].”
BackgroundInfluentialSelf-citationA brain somatic RHEB doublet mutation causes focal cortical dysplasia type II
Zhao, S., Li, Z., Zhang, M., Zhang, L., Zheng, H., Ning, J., Wang, Y., Wang, F., Zhang, X., Gan, H., et al. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0277-4 · Cited by 166 · cited 3×
“Importantly, spontaneous tonic-clonic seizures were observed in P30 mice, and this was alleviated by administration of rapamycin [71].”
BackgroundGermline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy
Møller, R. S., Weckhuysen, S., Chipaux, M., Marsan, E., Taly, V., Bebin, E. M., Hiatt, S. M., Prokop, J. W., Bowling, K. M., Mei, D., et al. (2016) · Neurology Genetics · doi:10.1212/nxg.0000000000000118 · Cited by 160 · cited 4×
“Using laser capture microdissection, other studies have shown that somatic variants in HME and FCD were most highly enriched in dysmorphic neurons and/or balloon cells compared to other cell types [66,67,77].”
BackgroundInfluentialSelf-citationMalformations of Cortical Development and Epilepsy
Barkovich, A. J., Dobyns, W. B., & Guerrini, R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a022392 · Cited by 159 · cited 1×
“First described in 1835 [24], hemimegalencephaly (HME) is a cortical malformation characterised by abnormal enlargement of one cerebral hemisphere, with histopathological features generally indistinguishable from those of FCDII [25,26].”
Insulin signaling pathways in cortical dysplasia and TSC‐tubers: Tissue microarray analysis
Miyata, H., Chiang, A. C. Y., & Vinters, H. V. (2004) · Annals of Neurology · doi:10.1002/ana.20234 · Cited by 152 · cited 5×
“The most remarkable outcome of the two studies was the consistent finding that in balloon/giant cells and dysmorphic neurons from both FCD and TSC, enhanced immunoreactivity against p-S6 was observed.”
BackgroundInfluentialActivation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia
Ljungberg, M. C., Bhattacharjee, M. B., Lu, Y., Armstrong, D. L., Yoshor, D., Swann, J. W., Sheldon, M., & D'Arcangelo, G. (2006) · Annals of Neurology · doi:10.1002/ana.20949 · Cited by 152
Cilia, Wnt signaling, and the cytoskeleton
May-Simera, H. L., & Kelley, M. W. (2012) · Cilia · doi:10.1186/2046-2530-1-7 · Cited by 152
Developmental disruptions underlying brain abnormalities in ciliopathies
Guo, J., Higginbotham, H., Li, J., Nichols, J., Hirt, J., Ghukasyan, V., & Anton, E. S. (2015) · Nature Communications · doi:10.1038/ncomms8857 · Cited by 146
Familial cortical dysplasia caused by mutation in the mammalian target of rapamycin regulator NPRL3
Sim, J. C., Scerri, T., Fanjul‐Fernández, M., Riseley, J. R., Gillies, G., Pope, K., van Roozendaal, H., Heng, J. I., Mandelstam, S. A., McGillivray, G., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24502 · Cited by 141 · cited 3×
“Similarly, low coverage WES (mean depth 80X) and Sanger sequencing of brain-derived DNA from two individuals with FCD and a germline heterozygous NPRL3 variant did not detect additional somatic variants [50].”
BackgroundSelf-citationPrecise detection of low-level somatic mutation in resected epilepsy brain tissue
Sim, N. S., Ko, A., Kim, W. K., Kim, S. H., Kim, J. S., Shim, K.-W., Aronica, E., Mijnsbergen, C., Spliet, W. G. M., Koh, H. Y., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02052-6 · Cited by 137 · cited 2×
“The second study led by Lee and colleagues investigated brain tissue of 114 individuals with FCDII or HME [68], and identified pathogenic somatic PIK3CA variant in one (0.”
BackgroundSomatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy
Winawer, M. R., Griffin, N. G., Samanamud, J., Baugh, E. H., Rathakrishnan, D., Ramalingam, S., Zagzag, D., Schevon, C. A., Dugan, P., Hegde, M., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25243 · Cited by 132
Nguyen, L. H., Mahadeo, T., & Bordey, A. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2260-18.2019 · Cited by 126 · cited 2×
“While low RhebCA level did not induce seizures, intermediate and high RhebCA levels resulted in spontaneous and recurrent seizures increasing proportionally with higher dosage [78].”
BackgroundBonduelle, T., Hartlieb, T., Baldassari, S., Sim, N. S., Kim, S. H., Kang, H., Kobow, K., Coras, R., Chipaux, M., Dorfmüller, G., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01085-3 · Cited by 123
Self-citationSalamon, N., Andres, M., Chute, D. J., Nguyen, S. T., Chang, J. W., Huynh, M. N., Chandra, P. S., Andre, V. M., Cepeda, C., Levine, M. S., et al. (2006) · Brain · doi:10.1093/brain/awh681 · Cited by 120 · cited 1×
“This hypothesis is supported by previous report of monozygotic twins with one twin affected by HME but not the other [32].”
ResultMalformations of Cerebral Cortex Development: Molecules and Mechanisms
Juric-Sekhar, G., & Hevner, R. F. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012418-012927 · Cited by 117 · cited 1×
“Indeed, this finding is consistent with the microscopic observation that abnormal cells of FCD can appear as clusters on brain sections [99,100], suggesting that cells harbouring the somatic mutation can congregate at certain regions.”
ResultHsieh, L. S., Wen, J. H., Claycomb, K., Huang, Y., Harrsch, F. A., Naegele, J. R., Hyder, F., Buchanan, G. F., & Bordey, A. (2016) · Nature Communications · doi:10.1038/ncomms11753 · Cited by 116 · cited 3×
“The authors generated an IUE mouse model producing RhebCA, which successfully recapitulated FCD phenotypes including spontaneous seizures, cortical dyslamination and cytomegalic neurons [85].”
BackgroundPark, S. M., Lim, J. S., Ramakrishina, S., Kim, S. H., Kim, W. K., Lee, J., Kang, H.-C., Reiter, J. F., Kim, D. S., Kim, H. (., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.05.039 · Cited by 114 · cited 2×
“Notably, rescue of ciliogenesis by knocking down Ofd1 in IUE mutant mice restored Wnt signalling and cortical lamination, but did not reverse spontaneous seizures or cytomegalic neurons, suggesting that cortical dyslamination is not necessary for epileptogenesis in IUE mutant mice [79].”
BackgroundJackson, J. H. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480200090012 · Cited by 107
Cepeda, C., André, V. M., Vinters, H. V., Levine, M. S., & Mathern, G. W. (2005) · Epilepsia · doi:10.1111/j.1528-1167.2005.01013.x · Cited by 106
Familial cortical dysplasia type IIA caused by a germline mutation in DEPDC 5
Scerri, T., Riseley, J. R., Gillies, G., Pope, K., Burgess, R., Mandelstam, S. A., Dibbens, L., Chow, C. W., Maixner, W., Harvey, A. S., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.191 · Cited by 104
Self-citationFocal brain malformations: Seizures, signaling, sequencing
Crino, P. B. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2009.02289.x · Cited by 97 · cited 1×
“These findings further expanded the spectrum of disorders related to the mTOR pathway, a group of conditions first referred to by Crino as “mTORopathies” [31].”
BackgroundDetection of human papillomavirus in human focal cortical dysplasia type IIB
Chen, J., Tsai, V., Parker, W. E., Aronica, E., Baybis, M., & Crino, P. B. (2012) · Annals of Neurology · doi:10.1002/ana.23795 · Cited by 84 · cited 2×
“While the involvement of environmental factors such as viral infection [93,94] cannot be excluded, these factors alone are insufficient to explain the re‐ maining cases without a genetic diagnosis.”
BackgroundWnt Signaling Regulates Multipolar-to-Bipolar Transition of Migrating Neurons in the Cerebral Cortex
Boitard, M., Bocchi, R., Egervari, K., Petrenko, V., Viale, B., Gremaud, S., Zgraggen, E., Salmon, P., & Kiss, J. Z. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.061 · Cited by 83 · cited 1×
“The authors further showed that disrupted neuronal ciliogenesis led to cortical dyslamination in IUE mutant mice by abrogating Wnt signalling, which is responsible for neuronal polarization and proper cortical lamination [84].”
BackgroundHemispheric cortical dysplasia secondary to a mosaic somatic mutation in MTOR
Leventer, R. J., Scerri, T., Marsh, A. P. L., Pope, K., Gillies, G., Maixner, W., MacGregor, D., Harvey, A. S., Delatycki, M. B., Amor, D. J., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001594 · Cited by 80
Self-citationSecond‐hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA
Lee, W. S., Stephenson, S. E. M., Howell, K. B., Pope, K., Gillies, G., Wray, A., Maixner, W., Mandelstam, S. A., Berkovic, S. F., Scheffer, I. E., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.50815 · Cited by 78 · cited 8×
“In an individual with FCDIIA, somatic mutation load in five brain regions were analysed, with the highest mutation load identified in the region with frequent, high voltage spike-waves and fast ripples [66].”
BackgroundMethodResultInfluentialSelf-citationBrain somatic mutations in SLC35A2 cause intractable epilepsy with aberrant N-glycosylation
Sim, N. S., Seo, Y., Lim, J. S., Kim, W. K., Son, H., Kim, H. D., Kim, S., An, H. J., Kang, H.-C., Kim, S. H., et al. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000294 · Cited by 77
Cerebrospinal fluid liquid biopsy for detecting somatic mosaicism in brain
Ye, Z., Chatterton, Z., Pflueger, J., Damiano, J. A., McQuillan, L., Simon Harvey, A., Malone, S., Do, H., Maixner, W., Schneider, A., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcaa235 · Cited by 77
Self-citationEpileptic spasms are a feature of DEPDC5 mTORopathy
Carvill, G. L., Crompton, D. E., Regan, B. M., McMahon, J. M., Saykally, J., Zemel, M., Schneider, A. L., Dibbens, L., Howell, K. B., Mandelstam, S., et al. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000016 · Cited by 76
Self-citationMolecular Pathogenesis of Focal Cortical Dysplasia and Hemimegalencephaly
Crino, P. B. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200041101 · Cited by 73
Kim, J. K., Cho, J., Kim, S. H., Kang, H.-C., Kim, D.-S., Kim, V. N., & Lee, J. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127032 · Cited by 66
Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation
Nascimento, F. A., Borlot, F., Cossette, P., Minassian, B. A., & Andrade, D. M. (2015) · Neurology Genetics · doi:10.1212/nxg.0000000000000028 · Cited by 63
Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy
Pelorosso, C., Watrin, F., Conti, V., Buhler, E., Gelot, A., Yang, X., Mei, D., McEvoy-Venneri, J., Manent, J.-B., Cetica, V., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz194 · Cited by 62 · cited 1×
“Arg232His) detected in brain and blood, were identified in an individual with HME [69].”
BackgroundSoriano, E., Dumesnil, N., Auladell, C., Cohen-Tannoudji, M., & Sotelo, C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11676 · Cited by 60 · cited 1×
“The nature of this migration process results in an interspersed population of cells from different origins [98].”
BackgroundCo-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly
Aronica, E., Boer, K., Baybis, M., Yu, J., & Crino, P. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0225-6 · Cited by 58
Detection of Brain Somatic Mutations in Cerebrospinal Fluid from Refractory Epilepsy Patients
Kim, S., Baldassari, S., Sim, N. S., Chipaux, M., Dorfmüller, G., Kim, D. S., Chang, W. S., Taly, V., Lee, J. H., & Baulac, S. (2021) · Annals of Neurology · doi:10.1002/ana.26080 · Cited by 58
Self-citationEctopic HCN4 expression drives mTOR-dependent epilepsy in mice
Hsieh, L. S., Wen, J. H., Nguyen, L. H., Zhang, L., Getz, S. A., Torres-Reveron, J., Wang, Y., Spencer, D. D., & Bordey, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc1492 · Cited by 57
Lodato, M. A., & Walsh, C. A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz191 · Cited by 56
Filamin A inhibition reduces seizure activity in a mouse model of focal cortical malformations
Zhang, L., Huang, T., Teaw, S., Nguyen, L. H., Hsieh, L. S., Gong, X., Burns, L. H., & Bordey, A. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0289 · Cited by 56
Serum MicroRNA-4521 is a Potential Biomarker for Focal Cortical Dysplasia with Refractory Epilepsy
Wang, X., Sun, Y., Tan, Z., Che, N., Ji, A., Luo, X., Sun, X., Li, X., Yang, K., Wang, G., et al. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1773-0 · Cited by 55 · cited 1×
“Identification of microRNA candidates in FCD brain tissue followed by validation of the candidates in serum-derived microRNA found miR-4521 [91] and miR-323a-5p [92] to be upregulated in both FCD brain tissue and serum, suggesting their potential as biomarkers for FCD.”
BackgroundNon–Cell Autonomous Epileptogenesis in Focal Cortical Dysplasia
Koh, H. Y., Jang, J., Ju, S. H., Kim, R., Cho, G., Kim, D. S., Sohn, J., Paik, S., & Lee, J. H. (2021) · Annals of Neurology · doi:10.1002/ana.26149 · Cited by 51 · cited 1×
“A recent study added further insights into the mechanism of epileptogenesis in FCD by demonstrating that neurons carrying somatic MTOR variants can cause hyperexcitability in nearby non-mutated neurons in a non-cell autonomous manner [86].”
BackgroundOn Hypertrophy and Atrophy of the Brain
Sims, J. (1835) · Journal of the Royal Society of Medicine · doi:10.1177/095952873501900120 · Cited by 49
Enright, N., Simonato, M., & Henshall, D. C. (2018) · Epilepsia Open · doi:10.1002/epi4.12275 · Cited by 48
Gradient of brain mosaic RHEB variants causes a continuum of cortical dysplasia
Lee, W. S., Baldassari, S., Chipaux, M., Adle‐Biassette, H., Stephenson, S. E. M., Maixner, W., Harvey, A. S., Lockhart, P. J., Baulac, S., & Leventer, R. J. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51286 · Cited by 40 · cited 2×
“Using laser capture microdissection, other studies have shown that somatic variants in HME and FCD were most highly enriched in dysmorphic neurons and/or balloon cells compared to other cell types [66,67,77].”
MethodResultSelf-citationSomatic SLC35A2 mosaicism correlates with clinical findings in epilepsy brain tissue
Miller, K. E., Koboldt, D. C., Schieffer, K. M., Bedrosian, T. A., Crist, E. R., Sheline, A., Leraas, K., Magrini, V. J., Zhong, H., Brennan, P., et al. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000460 · Cited by 39 · cited 2×
“In studies where multiple tissue samples were collected from the same individual, the concept of a “mutation gradient” was discussed [51,62,66,74].”
BackgroundA neuropathological study of two autopsy cases of syndromic hemimegalencephaly
Boer, K., Troost, D., Spliet, W. G. M., Redeker, S., Crino, P. B., & Aronica, E. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00818.x · Cited by 38
miRNA expression analysis in cortical dysplasia: Regulation of mTOR and LIS1 pathway
Lee, J. Y., Park, A.-K., Lee, E.-S., Park, W., Park, S., Choi, J. W., Phi, J. H., Wang, K., & Kim, S. (2014) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.01.005 · Cited by 36 · cited 1×
“Similarly, two other studies used microRNA microarray analysis to identify differentially expressed microRNA in FCD brain tissue, and suggested that some microRNAs may influence not only mTOR signalling pathway, but also LIS1 [88] and Hippo pathways [89].”
ResultSalinas, V., Vega, P., Piccirilli, M. V., Chicco, C., Ciraolo, C., Christiansen, S., Consalvo, D., Perez-Maturo, J., Medina, N., González-Morón, D., et al. (2019) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2018.11.005 · Cited by 34 · cited 1×
“Glu40Val) variant was initially reported in an individual with HME [70].”
BackgroundXu, Q., Uliel-Sibony, S., Dunham, C., Sarnat, H., Flores-Sarnat, L., Brunga, L., Davidson, S., Lo, W., Shlien, A., Connolly, M., et al. (2018) · Journal of Child Neurology · doi:10.1177/0883073818813238 · Cited by 34
Is focal cortical dysplasia sporadic? Family evidence for genetic susceptibility
Leventer, R. J., Jansen, F. E., Mandelstam, S. A., Ho, A., Mohamed, I., Sarnat, H. B., Kato, M., Fukasawa, T., Saitsu, H., Matsumoto, N., et al. (2014) · Epilepsia · doi:10.1111/epi.12533 · Cited by 33
Self-citationDysregulation of NEUROG2 plays a key role in focal cortical dysplasia
Avansini, S. H., Torres, F. R., Vieira, A. S., Dogini, D. B., Rogério, F., Coan, A. C., Morita, M. E., Guerreiro, M. M., Yasuda, C. L., Secolin, R., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25187 · Cited by 31 · cited 2×
“By analysing the predicted target of these microRNAs, the authors found abnormal upregulation of NEUROG2, which encodes a transcription factor involved in neuronal differentiation, suggesting that a disrupted differentiation process in neurons may underlie FCD [87].”
BackgroundViral infection and focal cortical dysplasia
Liu, S., Lu, L.-X., Cheng, X., Xu, G., & Yang, H. (2013) · Annals of Neurology · doi:10.1002/ana.24037 · Cited by 25 · cited 2×
“While the involvement of environmental factors such as viral infection [93,94] cannot be excluded, these factors alone are insufficient to explain the re‐ maining cases without a genetic diagnosis.”
BackgroundChe, N., Zu, G., Zhou, T., Wang, X., Sun, Y., Tan, Z., Liu, Y., Wang, D., Luo, X., Zhao, Z., et al. (2016) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2016.0096 · Cited by 24 · cited 1×
“Identification of microRNA candidates in FCD brain tissue followed by validation of the candidates in serum-derived microRNA found miR-4521 [91] and miR-323a-5p [92] to be upregulated in both FCD brain tissue and serum, suggesting their potential as biomarkers for FCD.”
BackgroundRossini, L., Medici, V., Tassi, L., Cardinale, F., Tringali, G., Bramerio, M., Villani, F. S., Spreafico, R., & Garbelli, R. (2014) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-2-45 · Cited by 19 · cited 1×
“Indeed, this finding is consistent with the microscopic observation that abnormal cells of FCD can appear as clusters on brain sections [99,100], suggesting that cells harbouring the somatic mutation can congregate at certain regions.”
ResultHoelz, H., Coppenrath, E., Hoertnagel, K., Roser, T., Tacke, M., Gerstl, L., & Borggraefe, I. (2017) · Clinical EEG and Neuroscience · doi:10.1177/1550059417697841 · Cited by 17
Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB
Li, L., Liu, C., Li, T., Guan, Y., Zhou, J., Qi, X., Yang, Y., Deng, J., Xu, Q., & Luan, G. (2015) · Journal of Child Neurology · doi:10.1177/0883073815609148 · Cited by 13 · cited 1×
“Similarly, two other studies used microRNA microarray analysis to identify differentially expressed microRNA in FCD brain tissue, and suggested that some microRNAs may influence not only mTOR signalling pathway, but also LIS1 [88] and Hippo pathways [89].”
ResultCompassionate use of everolimus for refractory epilepsy in a patient with MTOR mosaic mutation
Hadouiri, N., Darmency, V., Guibaud, L., Arzimanoglou, A. A., Sorlin, A., Carmignac, V., Rivière, J., Huet, F., Luu, M., Bardou, M., et al. (2020) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2020.104036 · Cited by 13
Dimartino, P., Mariani, V., Marconi, C., Minardi, R., Bramerio, M., Licchetta, L., Menghi, V., Morandi, L., Magini, P., Mongelli, P., et al. (2020) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00488-1 · Cited by 5
Essay on the origin and evolution of neuropathology
Roizin, L. (1957) · Psychiatric Quarterly · doi:10.1007/bf01568748 · Cited by 4
Dysmorphic neuron density underlies intrinsic epileptogenicity of the centre of cortical tubersPreprint
Stephenson, S. E. M., Owens, H. G., Richards, K., Lee, W. S., D’Arcy, C. E., Barton, S., Mandelstam, S. A., Maixner, W. J., MacGregor, D. P., Petrou, S., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/621607 · Cited by 2
Self-citation
Research works printed but not linked: 2
- Horsley, 1886, Brain Surgery, Br. Med. J., 2, 670
- Stephenson, S.E.M., Owens, H.G., Richards, K.L., Lee, W.S., D’Arcy, C., Barton, S., Mandelstam, S.A., Maixner, W.J., MacGregor, D., and Petrou, S. (2019). Dysmorphic neuron density is highest in the centre of epileptogenic cortical tubers. bioRxiv, 621607.
Cited by
Developmental and epileptic encephalopathies
Scheffer, I. E., Zuberi, S., Mefford, H. C., Guerrini, R., & McTague, A. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00546-6 · Cited by 158
“[H2] Cell signalling Several cell signalling pathways have been implicated in epilepsies, with the most prominent being the mechanistic (formerly mammalian) target of rapamycin (mTOR) pathway 122, 123 .”
Anti-seizure gene therapy for focal cortical dysplasia
Almacellas‐Barbanoj, A., Graham, R., Maffei, B., Carpenter, J. C., Leite, M., Hoke, J., Hardjo, F., Scott-Solache, J., Chimonides, C., Schorge, S., et al. (2023) · Brain · doi:10.1093/brain/awad387 · Cited by 44
Brain somatic mosaicism in epilepsy: Bringing results back to the clinic
D’Gama, A. M., & Poduri, A. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106104 · Cited by 41
Congenital Brain Malformations: An Integrated Diagnostic Approach
Chaudhari, B. P., & Ho, M. (2022) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2022.100973 · Cited by 36
Boff, M. O., Xavier, F. A. C., Diz, F. M., Gonçalves, J. B., Ferreira, L. O., Zambeli, J., Pazzin, D. B., Previato, T. T. R., Erwig, H. S., Gonçalves, J. I. B., et al. (2025) · Cells · doi:10.3390/cells14090662 · Cited by 25
“Hemimegalencephaly (HME) is a malformation that histopathologically resembles FCD [44] and is defined by the presence of anomalous neuronal and glial cells within one hemisphere of the brain [45].”
Metadata
- Authors
- Lee, W. S., Baldassari, S., Stephenson, S. E. M., Lockhart, P. J., Baulac, S., & Leventer, R. J.
- Affiliations
- The University of Melbourne (AU)
- Centre National de la Recherche Scientifique (FR)
- Royal Children's Hospital (AU)
- Corresponding author
- Baulac, Stéphanie
- Leventer, Richard J.
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-01-25
- Volume
- 23
- Issue
- 3
- Pages
- 1344
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8835853
- OpenAlex
- W4210390266
- Cited by
- 45
- References
- 114
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 8 · 2023: 13 · 2022: 7
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Medical Research Council
- National Health and Medical Research Council (1161549)
- H2020 European Research Council (682345)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- focal cortical dysplasia type II, mTOR signaling, epileptogenesis, drug-resistant epilepsy, somatic mosaicism, two-hit mechanism, balloon cells, dysmorphic neurons, human brain tissue
- MeSH terms
- Drug Resistant Epilepsy, Brain, Epilepsy, Humans, Mutation, Neurons, Signal Transduction, Malformations of Cortical Development, TOR Serine-Threonine Kinases, Malformations of Cortical Development, Group I
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.